Streetbeat News

Regulatory

PLUG

The U.S. Securities and Exchange Commission (SEC) has announced that Plug Power will pay a $1.25 million civil fine to settle charges over reporting, accounting, and controls failures that required a multi-year restatement.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:11 pm

ABBV

Allergan Aesthetics, an AbbVie company, announced that the Journal of Cosmetic Dermatology published results from a year-long study evaluating the impact of BOTOX Cosmetic on upper facial lines in adults. The study found that 90.5% of patients were satisfied with a natural look 30 days after treatment, and this satisfaction was sustained by over 80% of patients throughout the 12-month study period.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:10 pm

XBIT

XBiotech Inc. has completed enrollment for the Phase II portion of its 1-BETTER study, a clinical study for Natrunix in combination with chemotherapy for treating pancreatic cancer. Natrunix is an antibody therapy that binds and neutralizes a substance that causes tumor growth and spread. The Phase II study enrolled 65 subjects to receive either Natrunix in combination with chemotherapy or a placebo. Key endpoints are safety and tolerability, progression-free survival, overall survival, and time-to-treatment-failure.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:08 pm

MA

V

Visa and Mastercard are preparing to raise credit-card fees. The fee increases are scheduled to start in October and April, according to the Wall Street Journal.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:04 pm

BNTX

PFE

The European Commission is set to review the Committee for Medicinal Products for Human Use's recommendation and is expected to make a final decision soon. The companies BNTX and PFE are mentioned in the context of this news.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 1:03 pm

BNTX

PFE

Pfizer and BioNTech have announced that their COVID-19 vaccine doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 1:02 pm

BNTX

PFE

Pfizer and BioNTech have received a positive opinion from the Committee for Medical Products for Human Use for their Omicron XBB.1.5-adapted Covid-19 vaccine in the European Union.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 1:01 pm

RBT

Rubicon Technologies (NYSE:RBT) has announced the purchase of the remaining self-liquidating note from Yorkville by entities affiliated with the company's largest investors, Rodina Capital and their partners. The note has been fully converted into shares. This move is part of Rubicon's strategy to improve its liquidity position and accelerate its progress to profitability. The company has recently announced a second consecutive quarter of record Adjusted Gross Profit at approximately $18 million.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 12:57 pm

BA

The U.S. Federal Aviation Administration (FAA) has proposed an airworthiness directive for certain Airbus Canada A-220 airliners due to issues with electrical connectors. The directive could potentially affect the operations of airlines using these aircraft.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 12:57 pm

DGX

Quest Diagnostics has been granted FDA breakthrough designation for its Adeno-Associated Virus (AAV) test. Additionally, Quest has expanded its collaboration with Sarepta Therapeutics to develop AAV Companion Diagnostics for Sarepta's gene therapies.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 12:41 pm